Journal
MOLECULES
Volume 26, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/molecules26051479
Keywords
antibody– drug conjugates; drug delivery; vaccines; antibiotics; conjugated vaccines; targeted vaccines; bioconjugation; nanoparticles
Funding
- National Institutes of Health [RO1AI123129]
- Department of Defense [W81XH1910661]
Ask authors/readers for more resources
Bioconjugation allows scientists to combine multiple functional elements into one biological unit, targeting specific sites or cell types to enhance response or activity. This targeted approach is particularly advantageous in cancer treatments, where delivering chemotherapies selectively can limit side effects and improve efficacy. Additionally, conjugation can help in treating bacterial infections more selectively and enhancing vaccine efficacy without compromising safety.
Bioconjugation has allowed scientists to combine multiple functional elements into one biological or biochemical unit. This assembly can result in the production of constructs that are targeted to a specific site or cell type in order to enhance the response to, or activity of, the conjugated moiety. In the case of cancer treatments, selectively targeting chemotherapies to the cells of interest limit harmful side effects and enhance efficacy. Targeting through conjugation is also advantageous in delivering treatments to difficult-to-reach tissues, such as the brain or infections deep in the lung. Bacterial infections can be more selectively treated by conjugating antibiotics to microbe-specific entities; helping to avoid antibiotic resistance across commensal bacterial species. In the case of vaccine development, conjugation is used to enhance efficacy without compromising safety. In this work, we will review the previously mentioned areas in which bioconjugation has created new possibilities and advanced treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available